 Laura Saba
Concepts (573)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcohol Drinking | 18 | 2021 | 651 | 2.200 |
Why?
| | Quantitative Trait Loci | 24 | 2022 | 305 | 1.900 |
Why?
| | Gene Regulatory Networks | 7 | 2023 | 228 | 1.390 |
Why?
| | Ethanol | 15 | 2020 | 538 | 1.320 |
Why?
| | Transcriptome | 8 | 2022 | 725 | 1.270 |
Why?
| | Brain | 19 | 2023 | 2371 | 1.140 |
Why?
| | Gene Expression Profiling | 16 | 2021 | 1518 | 1.110 |
Why?
| | Quantitative Trait, Heritable | 7 | 2017 | 116 | 1.080 |
Why?
| | High-Throughput Nucleotide Sequencing | 6 | 2021 | 439 | 1.010 |
Why?
| | Rats, Inbred Strains | 7 | 2019 | 362 | 0.980 |
Why?
| | Systems Biology | 3 | 2021 | 54 | 0.940 |
Why?
| | Liver | 9 | 2019 | 1637 | 0.850 |
Why?
| | Genetic Predisposition to Disease | 12 | 2018 | 2086 | 0.840 |
Why?
| | Adrenocortical Carcinoma | 5 | 2023 | 47 | 0.810 |
Why?
| | MicroRNAs | 6 | 2019 | 600 | 0.790 |
Why?
| | Sequence Analysis, RNA | 7 | 2022 | 385 | 0.750 |
Why?
| | Phenotype | 15 | 2020 | 2796 | 0.750 |
Why?
| | RNA | 6 | 2021 | 809 | 0.740 |
Why?
| | Rats | 18 | 2023 | 4958 | 0.730 |
Why?
| | Polymorphism, Single Nucleotide | 17 | 2022 | 1880 | 0.720 |
Why?
| | Polyadenylation | 1 | 2021 | 37 | 0.710 |
Why?
| | Protein Carbonylation | 7 | 2019 | 51 | 0.700 |
Why?
| | RNA, Long Noncoding | 2 | 2020 | 154 | 0.700 |
Why?
| | Mitotane | 5 | 2023 | 6 | 0.700 |
Why?
| | Adrenal Cortex Neoplasms | 4 | 2023 | 48 | 0.670 |
Why?
| | Animals | 54 | 2024 | 31708 | 0.660 |
Why?
| | Software | 7 | 2019 | 530 | 0.650 |
Why?
| | Drug Tolerance | 4 | 2020 | 79 | 0.630 |
Why?
| | Tunica Media | 1 | 2018 | 35 | 0.590 |
Why?
| | Tunica Intima | 1 | 2018 | 78 | 0.580 |
Why?
| | Databases, Genetic | 5 | 2017 | 206 | 0.580 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 113 | 0.560 |
Why?
| | Carotid Stenosis | 1 | 2018 | 79 | 0.560 |
Why?
| | Genetic Variation | 4 | 2019 | 870 | 0.550 |
Why?
| | Carotid Arteries | 1 | 2018 | 180 | 0.530 |
Why?
| | Alcoholism | 8 | 2021 | 713 | 0.530 |
Why?
| | Complement C3 | 4 | 2021 | 188 | 0.510 |
Why?
| | Central Nervous System Depressants | 4 | 2010 | 81 | 0.490 |
Why?
| | Models, Statistical | 1 | 2018 | 599 | 0.470 |
Why?
| | Liver Diseases, Alcoholic | 4 | 2019 | 81 | 0.460 |
Why?
| | Internet | 6 | 2010 | 596 | 0.440 |
Why?
| | Bayes Theorem | 5 | 2020 | 329 | 0.420 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2019 | 740 | 0.410 |
Why?
| | Mice | 31 | 2022 | 14871 | 0.400 |
Why?
| | Genomics | 5 | 2018 | 635 | 0.380 |
Why?
| | Antineoplastic Agents, Hormonal | 4 | 2023 | 138 | 0.370 |
Why?
| | Aldehydes | 5 | 2019 | 138 | 0.360 |
Why?
| | Glutathione Transferase | 4 | 2019 | 93 | 0.350 |
Why?
| | Mice, Inbred Strains | 9 | 2020 | 396 | 0.350 |
Why?
| | Male | 57 | 2021 | 55606 | 0.340 |
Why?
| | Health Education | 3 | 2008 | 323 | 0.340 |
Why?
| | Rats, Wistar | 3 | 2020 | 368 | 0.320 |
Why?
| | Genetic Association Studies | 5 | 2017 | 339 | 0.320 |
Why?
| | Synaptic Transmission | 1 | 2010 | 227 | 0.320 |
Why?
| | Tandem Mass Spectrometry | 5 | 2024 | 412 | 0.290 |
Why?
| | Humans | 68 | 2023 | 114698 | 0.280 |
Why?
| | Point Mutation | 2 | 2001 | 216 | 0.280 |
Why?
| | beta-Thalassemia | 4 | 2013 | 23 | 0.270 |
Why?
| | Genes, Regulator | 1 | 2006 | 34 | 0.270 |
Why?
| | Oxidative Stress | 4 | 2019 | 1076 | 0.260 |
Why?
| | PTEN Phosphohydrolase | 2 | 2018 | 140 | 0.260 |
Why?
| | Nanoparticles | 2 | 2020 | 313 | 0.260 |
Why?
| | Adenylyl Cyclases | 3 | 2012 | 83 | 0.260 |
Why?
| | Smoking Prevention | 1 | 2006 | 157 | 0.250 |
Why?
| | Female | 50 | 2022 | 59520 | 0.250 |
Why?
| | Genome-Wide Association Study | 2 | 2022 | 1177 | 0.250 |
Why?
| | Models, Genetic | 5 | 2019 | 562 | 0.250 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2017 | 164 | 0.240 |
Why?
| | Recombination, Genetic | 2 | 2017 | 176 | 0.240 |
Why?
| | Rats, Inbred SHR | 4 | 2018 | 41 | 0.240 |
Why?
| | Genotype | 10 | 2022 | 1760 | 0.240 |
Why?
| | Heart Transplantation | 2 | 2021 | 665 | 0.240 |
Why?
| | Pituitary-Adrenal System | 3 | 2017 | 130 | 0.230 |
Why?
| | Gene Expression Regulation | 7 | 2019 | 2320 | 0.230 |
Why?
| | Mice, Inbred C57BL | 11 | 2021 | 4694 | 0.230 |
Why?
| | Corneal Injuries | 1 | 2024 | 33 | 0.220 |
Why?
| | Base Sequence | 6 | 2021 | 2114 | 0.210 |
Why?
| | Receptors, GABA-A | 2 | 2018 | 82 | 0.210 |
Why?
| | Rats, Inbred BN | 3 | 2018 | 52 | 0.200 |
Why?
| | Mustard Gas | 1 | 2024 | 117 | 0.200 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 119 | 0.200 |
Why?
| | Behavior, Addictive | 2 | 2020 | 81 | 0.190 |
Why?
| | Breast Neoplasms | 5 | 2019 | 1862 | 0.190 |
Why?
| | Leukopenia | 1 | 2021 | 27 | 0.190 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 16 | 0.190 |
Why?
| | Chromatography, Liquid | 5 | 2024 | 347 | 0.190 |
Why?
| | Complement Activation | 2 | 2021 | 340 | 0.190 |
Why?
| | Magnesium Deficiency | 1 | 2020 | 2 | 0.180 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2021 | 109 | 0.180 |
Why?
| | Myocardium | 2 | 2018 | 913 | 0.180 |
Why?
| | Genome | 3 | 2017 | 271 | 0.180 |
Why?
| | Mycophenolic Acid | 1 | 2021 | 77 | 0.180 |
Why?
| | Algorithms | 3 | 2023 | 1470 | 0.180 |
Why?
| | Hydroxycholesterols | 1 | 2020 | 3 | 0.180 |
Why?
| | Signal Transduction | 7 | 2019 | 4515 | 0.180 |
Why?
| | Trace Elements | 1 | 2020 | 45 | 0.170 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2020 | 16 | 0.170 |
Why?
| | Liposomes | 2 | 2019 | 146 | 0.170 |
Why?
| | Nicotinamide Mononucleotide | 1 | 2019 | 9 | 0.170 |
Why?
| | Complement Inactivating Agents | 1 | 2020 | 41 | 0.170 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 2019 | 20 | 0.170 |
Why?
| | Osteoprotegerin | 3 | 2009 | 23 | 0.170 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 35 | 0.170 |
Why?
| | Adult | 28 | 2020 | 30553 | 0.170 |
Why?
| | User-Computer Interface | 1 | 2020 | 140 | 0.170 |
Why?
| | Pesticides | 1 | 2019 | 49 | 0.160 |
Why?
| | Drosophila | 1 | 2020 | 133 | 0.160 |
Why?
| | Hippocampus | 2 | 2022 | 693 | 0.160 |
Why?
| | Genetic Markers | 1 | 2020 | 320 | 0.160 |
Why?
| | Sex Characteristics | 4 | 2021 | 641 | 0.160 |
Why?
| | Anthracenes | 1 | 2019 | 27 | 0.160 |
Why?
| | Reflex, Righting | 2 | 2018 | 10 | 0.160 |
Why?
| | Gene Expression | 3 | 2014 | 1421 | 0.160 |
Why?
| | Protein Corona | 1 | 2019 | 5 | 0.160 |
Why?
| | Mice, Inbred DBA | 5 | 2019 | 174 | 0.160 |
Why?
| | Drosophila Proteins | 1 | 2020 | 164 | 0.160 |
Why?
| | Middle Aged | 25 | 2021 | 26738 | 0.160 |
Why?
| | Opsonin Proteins | 1 | 2019 | 25 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 182 | 0.160 |
Why?
| | Cushing Syndrome | 2 | 2010 | 10 | 0.160 |
Why?
| | Eicosanoids | 1 | 2019 | 54 | 0.160 |
Why?
| | Proteome | 2 | 2020 | 339 | 0.160 |
Why?
| | Fluorenes | 1 | 2019 | 38 | 0.160 |
Why?
| | Chimera | 1 | 2019 | 59 | 0.160 |
Why?
| | Hallucinogens | 1 | 2020 | 73 | 0.160 |
Why?
| | Antioxidants | 2 | 2019 | 530 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 165 | 0.160 |
Why?
| | Biomarkers | 6 | 2020 | 3408 | 0.150 |
Why?
| | Lymphocytes | 1 | 2020 | 330 | 0.150 |
Why?
| | Steroid 11-beta-Hydroxylase | 1 | 2018 | 3 | 0.150 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 9 | 0.150 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2020 | 179 | 0.150 |
Why?
| | Immunoglobulins | 1 | 2019 | 143 | 0.150 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 94 | 0.150 |
Why?
| | Computational Biology | 3 | 2017 | 530 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.150 |
Why?
| | Metabolic Clearance Rate | 1 | 2018 | 102 | 0.150 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 96 | 0.150 |
Why?
| | Cell Degranulation | 1 | 2018 | 39 | 0.150 |
Why?
| | Receptors, Nicotinic | 1 | 2020 | 274 | 0.150 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 98 | 0.150 |
Why?
| | Graft Rejection | 1 | 2021 | 513 | 0.150 |
Why?
| | Smoking | 2 | 2020 | 1383 | 0.150 |
Why?
| | Food Preferences | 2 | 2009 | 108 | 0.150 |
Why?
| | Angiography, Digital Subtraction | 1 | 2018 | 44 | 0.150 |
Why?
| | Silver | 1 | 2018 | 27 | 0.150 |
Why?
| | Interleukin-6 | 3 | 2006 | 676 | 0.150 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 71 | 0.150 |
Why?
| | Ferrosoferric Oxide | 1 | 2017 | 25 | 0.140 |
Why?
| | Adipose Tissue, Brown | 1 | 2017 | 43 | 0.140 |
Why?
| | Monocytes | 1 | 2020 | 504 | 0.140 |
Why?
| | Hepatitis | 1 | 2017 | 45 | 0.140 |
Why?
| | Dextrans | 1 | 2017 | 73 | 0.140 |
Why?
| | Mast Cells | 1 | 2018 | 116 | 0.140 |
Why?
| | Multifactorial Inheritance | 1 | 2018 | 122 | 0.140 |
Why?
| | Mitochondria | 2 | 2021 | 747 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 344 | 0.140 |
Why?
| | Web Browser | 1 | 2017 | 12 | 0.140 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 134 | 0.140 |
Why?
| | Seizures | 1 | 2020 | 340 | 0.140 |
Why?
| | Depressive Disorder, Major | 2 | 2012 | 301 | 0.140 |
Why?
| | Liver Diseases | 1 | 2019 | 255 | 0.140 |
Why?
| | Globins | 2 | 1997 | 21 | 0.140 |
Why?
| | Lod Score | 1 | 2016 | 65 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 2 | 2015 | 399 | 0.130 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 63 | 0.130 |
Why?
| | Anxiety | 1 | 2022 | 840 | 0.130 |
Why?
| | Cholestasis | 1 | 2019 | 225 | 0.130 |
Why?
| | Gene Ontology | 1 | 2016 | 46 | 0.130 |
Why?
| | Down Syndrome | 1 | 2021 | 335 | 0.130 |
Why?
| | Chromosomes, Mammalian | 1 | 2016 | 26 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.130 |
Why?
| | Doxorubicin | 1 | 2017 | 285 | 0.130 |
Why?
| | Choice Behavior | 2 | 2014 | 155 | 0.130 |
Why?
| | Pain Threshold | 2 | 2010 | 67 | 0.130 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2016 | 19 | 0.130 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2016 | 14 | 0.130 |
Why?
| | Circadian Rhythm | 2 | 2020 | 356 | 0.130 |
Why?
| | von Willebrand Factor | 1 | 2016 | 56 | 0.130 |
Why?
| | Aged | 14 | 2019 | 19074 | 0.130 |
Why?
| | Complement System Proteins | 1 | 2019 | 283 | 0.130 |
Why?
| | Hydrocortisone | 4 | 2012 | 267 | 0.130 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.130 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 245 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2021 | 645 | 0.130 |
Why?
| | beta Karyopherins | 1 | 2015 | 7 | 0.130 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 31 | 0.130 |
Why?
| | Consensus | 1 | 2018 | 537 | 0.120 |
Why?
| | Diet | 3 | 2008 | 1080 | 0.120 |
Why?
| | Dexamethasone | 2 | 2024 | 317 | 0.120 |
Why?
| | Herpesvirus 1, Human | 1 | 2016 | 76 | 0.120 |
Why?
| | Peptides | 1 | 2020 | 848 | 0.120 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2015 | 39 | 0.120 |
Why?
| | Immune System | 1 | 2016 | 172 | 0.120 |
Why?
| | Darkness | 1 | 2015 | 23 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 385 | 0.120 |
Why?
| | Proteomics | 4 | 2024 | 836 | 0.120 |
Why?
| | Neutrophils | 1 | 2020 | 1176 | 0.120 |
Why?
| | Mammography | 2 | 2006 | 105 | 0.120 |
Why?
| | Anti-HIV Agents | 1 | 2020 | 666 | 0.120 |
Why?
| | Allergens | 1 | 2018 | 413 | 0.120 |
Why?
| | Ultrasonography | 1 | 2018 | 634 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2017 | 245 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2018 | 2187 | 0.110 |
Why?
| | Atherosclerosis | 1 | 2018 | 341 | 0.110 |
Why?
| | Apoptosis | 2 | 2020 | 2363 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2019 | 951 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 858 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2019 | 2570 | 0.110 |
Why?
| | Species Specificity | 4 | 2014 | 542 | 0.110 |
Why?
| | Cannabis | 1 | 2020 | 384 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 219 | 0.110 |
Why?
| | Blood Pressure | 1 | 2020 | 1538 | 0.110 |
Why?
| | LDL-Receptor Related Proteins | 1 | 2013 | 6 | 0.110 |
Why?
| | Chloride Channels | 1 | 1993 | 35 | 0.110 |
Why?
| | Iron Overload | 1 | 2013 | 9 | 0.110 |
Why?
| | Glucocorticoids | 2 | 2009 | 532 | 0.110 |
Why?
| | Chromosome Mapping | 4 | 2020 | 487 | 0.110 |
Why?
| | Genes | 1 | 1993 | 223 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1141 | 0.110 |
Why?
| | Database Management Systems | 2 | 2017 | 47 | 0.110 |
Why?
| | Catalase | 2 | 2017 | 118 | 0.100 |
Why?
| | Kidney | 1 | 2019 | 1188 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1313 | 0.100 |
Why?
| | DNA Mutational Analysis | 4 | 2001 | 372 | 0.100 |
Why?
| | Hypertension | 1 | 2020 | 1056 | 0.100 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2012 | 36 | 0.100 |
Why?
| | Iron | 1 | 2013 | 233 | 0.100 |
Why?
| | Monoamine Oxidase | 1 | 2011 | 27 | 0.100 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 364 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1355 | 0.090 |
Why?
| | Rats, Long-Evans | 2 | 2021 | 98 | 0.090 |
Why?
| | Receptors, GABA | 1 | 2010 | 8 | 0.090 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 12 | 0.090 |
Why?
| | Area Under Curve | 3 | 2019 | 274 | 0.090 |
Why?
| | Bone Density | 2 | 2012 | 432 | 0.090 |
Why?
| | Disease Models, Animal | 5 | 2019 | 3535 | 0.090 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2010 | 2 | 0.090 |
Why?
| | RNA, Messenger | 5 | 2018 | 2553 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1144 | 0.090 |
Why?
| | Colonic Diseases, Functional | 2 | 2000 | 3 | 0.090 |
Why?
| | Cross-Sectional Studies | 5 | 2020 | 4410 | 0.090 |
Why?
| | Postmenopause | 1 | 2012 | 303 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 144 | 0.080 |
Why?
| | Morphine | 1 | 2010 | 121 | 0.080 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2009 | 7 | 0.080 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2785 | 0.080 |
Why?
| | Inflammation Mediators | 2 | 2024 | 477 | 0.080 |
Why?
| | Cyclooxygenase 2 | 2 | 2019 | 164 | 0.080 |
Why?
| | RANK Ligand | 1 | 2008 | 26 | 0.080 |
Why?
| | Blood Platelets | 1 | 2011 | 351 | 0.080 |
Why?
| | United States | 3 | 2018 | 12186 | 0.080 |
Why?
| | Breeding | 2 | 2014 | 55 | 0.080 |
Why?
| | Receptors, Glucocorticoid | 1 | 2009 | 130 | 0.070 |
Why?
| | Scleroderma, Systemic | 1 | 2008 | 96 | 0.070 |
Why?
| | Androgens | 1 | 2009 | 167 | 0.070 |
Why?
| | Membrane Proteins | 1 | 1993 | 1019 | 0.070 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2007 | 47 | 0.070 |
Why?
| | Adrenocorticotropic Hormone | 3 | 2017 | 128 | 0.070 |
Why?
| | Alanine Transaminase | 2 | 2019 | 142 | 0.070 |
Why?
| | Electronic Mail | 1 | 2007 | 54 | 0.070 |
Why?
| | Computer-Assisted Instruction | 1 | 2008 | 62 | 0.070 |
Why?
| | Hepatic Encephalopathy | 1 | 2007 | 19 | 0.070 |
Why?
| | Alcohol Dehydrogenase | 1 | 2006 | 15 | 0.070 |
Why?
| | Superoxide Dismutase | 2 | 2019 | 306 | 0.070 |
Why?
| | Computer Simulation | 2 | 2023 | 873 | 0.070 |
Why?
| | HIV Infections | 1 | 2020 | 2469 | 0.070 |
Why?
| | Adrenal Cortex | 1 | 2006 | 32 | 0.070 |
Why?
| | Oxidation-Reduction | 2 | 2020 | 923 | 0.070 |
Why?
| | Cytokine Receptor gp130 | 1 | 2006 | 10 | 0.070 |
Why?
| | Receptors, Interleukin-6 | 1 | 2006 | 34 | 0.070 |
Why?
| | Up-Regulation | 2 | 2019 | 808 | 0.070 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2006 | 108 | 0.070 |
Why?
| | Brain Chemistry | 2 | 2009 | 115 | 0.060 |
Why?
| | Australia | 1 | 2006 | 206 | 0.060 |
Why?
| | Prednisolone | 1 | 2006 | 75 | 0.060 |
Why?
| | Alleles | 2 | 2019 | 789 | 0.060 |
Why?
| | Health Planning Guidelines | 1 | 2006 | 25 | 0.060 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2006 | 102 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2006 | 249 | 0.060 |
Why?
| | Culture | 1 | 2006 | 124 | 0.060 |
Why?
| | Program Evaluation | 2 | 2007 | 822 | 0.060 |
Why?
| | Cell Line, Tumor | 3 | 2020 | 2710 | 0.060 |
Why?
| | Bone Resorption | 1 | 2006 | 73 | 0.060 |
Why?
| | Muscle Fatigue | 1 | 2006 | 94 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2020 | 2218 | 0.060 |
Why?
| | Exercise | 2 | 2006 | 1644 | 0.060 |
Why?
| | Phosphorylation | 2 | 2019 | 1569 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4411 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2021 | 3886 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2008 | 363 | 0.060 |
Why?
| | Health Promotion | 2 | 2008 | 686 | 0.060 |
Why?
| | Elective Surgical Procedures | 1 | 2006 | 151 | 0.060 |
Why?
| | Metabolomics | 2 | 2019 | 521 | 0.060 |
Why?
| | ROC Curve | 2 | 2019 | 442 | 0.060 |
Why?
| | Schools | 1 | 2008 | 399 | 0.060 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2006 | 109 | 0.060 |
Why?
| | Cystic Fibrosis | 1 | 1993 | 955 | 0.060 |
Why?
| | Environmental Exposure | 1 | 2008 | 372 | 0.060 |
Why?
| | Case-Control Studies | 4 | 2017 | 3003 | 0.060 |
Why?
| | Sports | 1 | 2006 | 187 | 0.060 |
Why?
| | Adolescent | 6 | 2019 | 17853 | 0.050 |
Why?
| | Analgesics, Opioid | 1 | 2010 | 771 | 0.050 |
Why?
| | Albumins | 1 | 2023 | 89 | 0.050 |
Why?
| | Retrospective Studies | 5 | 2021 | 12555 | 0.050 |
Why?
| | Mass Screening | 2 | 2010 | 1005 | 0.050 |
Why?
| | Cornea | 1 | 2024 | 102 | 0.050 |
Why?
| | Actin Cytoskeleton | 1 | 2024 | 93 | 0.050 |
Why?
| | Leptin | 1 | 2004 | 210 | 0.050 |
Why?
| | Rabbits | 1 | 2024 | 733 | 0.050 |
Why?
| | Microarray Analysis | 2 | 2015 | 118 | 0.050 |
Why?
| | Prostatic Neoplasms | 1 | 2009 | 921 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2008 | 1183 | 0.050 |
Why?
| | Health Behavior | 1 | 2007 | 704 | 0.050 |
Why?
| | Patient Compliance | 1 | 2006 | 525 | 0.050 |
Why?
| | Curriculum | 1 | 2008 | 819 | 0.050 |
Why?
| | Actins | 1 | 2024 | 381 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2006 | 1214 | 0.050 |
Why?
| | Risk Factors | 4 | 2019 | 8632 | 0.050 |
Why?
| | Killer Cells, Natural | 1 | 2004 | 380 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 797 | 0.050 |
Why?
| | Time Factors | 4 | 2019 | 6116 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 1982 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2006 | 376 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2001 | 91 | 0.050 |
Why?
| | Blotting, Western | 2 | 2015 | 1147 | 0.050 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2020 | 3 | 0.050 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 53 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2001 | 256 | 0.040 |
Why?
| | Rats, Inbred F344 | 1 | 2001 | 241 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 334 | 0.040 |
Why?
| | Oxysterols | 1 | 2020 | 2 | 0.040 |
Why?
| | Indians, North American | 1 | 2006 | 570 | 0.040 |
Why?
| | Magnesium | 1 | 2020 | 145 | 0.040 |
Why?
| | Cytomegalovirus | 1 | 2021 | 144 | 0.040 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 30 | 0.040 |
Why?
| | Carbon | 1 | 2021 | 156 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2020 | 55 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2006 | 1473 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2020 | 138 | 0.040 |
Why?
| | Kainic Acid | 1 | 2020 | 31 | 0.040 |
Why?
| | Metabolic Syndrome | 2 | 2017 | 321 | 0.040 |
Why?
| | DNA Primers | 1 | 2001 | 510 | 0.040 |
Why?
| | Substance Abuse Detection | 1 | 2020 | 62 | 0.040 |
Why?
| | Emtricitabine | 1 | 2020 | 147 | 0.040 |
Why?
| | Italy | 3 | 1997 | 92 | 0.040 |
Why?
| | Catheterization | 1 | 2000 | 159 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2019 | 52 | 0.040 |
Why?
| | Transplant Recipients | 1 | 2021 | 140 | 0.040 |
Why?
| | Protective Agents | 1 | 2019 | 37 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2019 | 88 | 0.040 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 61 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2019 | 86 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2019 | 139 | 0.040 |
Why?
| | Benchmarking | 1 | 2020 | 161 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 172 | 0.040 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 144 | 0.040 |
Why?
| | Colitis, Ulcerative | 1 | 2000 | 105 | 0.040 |
Why?
| | Sample Size | 1 | 2019 | 112 | 0.040 |
Why?
| | Pregnancy | 3 | 2020 | 5520 | 0.040 |
Why?
| | Cardiovascular Diseases | 2 | 2008 | 1727 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 374 | 0.040 |
Why?
| | Colorado | 3 | 2020 | 4100 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 45 | 0.040 |
Why?
| | Cerebellum | 1 | 2001 | 200 | 0.040 |
Why?
| | Sensation | 1 | 1999 | 44 | 0.040 |
Why?
| | Dronabinol | 1 | 2020 | 118 | 0.040 |
Why?
| | Protons | 1 | 2019 | 73 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 123 | 0.040 |
Why?
| | Receptors, AMPA | 1 | 2020 | 119 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 331 | 0.040 |
Why?
| | Caspase 3 | 1 | 2019 | 235 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2012 | 224 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 446 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 32 | 0.040 |
Why?
| | Normal Distribution | 1 | 2018 | 19 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 158 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2018 | 15 | 0.040 |
Why?
| | Metyrapone | 1 | 2018 | 2 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 301 | 0.040 |
Why?
| | Computer Graphics | 1 | 2018 | 41 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 1879 | 0.040 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 14 | 0.040 |
Why?
| | Inflammation | 2 | 2019 | 2480 | 0.040 |
Why?
| | Dinitrobenzenes | 1 | 2018 | 6 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 148 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 52 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 75 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 260 | 0.040 |
Why?
| | Receptors, IgE | 1 | 2018 | 40 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2019 | 6347 | 0.040 |
Why?
| | Fetal Development | 1 | 2020 | 248 | 0.040 |
Why?
| | Abdominal Pain | 1 | 1999 | 135 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 168 | 0.040 |
Why?
| | Magnetite Nanoparticles | 1 | 2017 | 28 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 25 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2007 | 2286 | 0.040 |
Why?
| | Thioredoxins | 1 | 2017 | 33 | 0.040 |
Why?
| | Tuberculosis | 1 | 2020 | 241 | 0.040 |
Why?
| | Organ Specificity | 1 | 2018 | 268 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 296 | 0.040 |
Why?
| | DNA Damage | 1 | 2019 | 351 | 0.040 |
Why?
| | Heterozygote | 3 | 1994 | 251 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 61 | 0.040 |
Why?
| | Crigler-Najjar Syndrome | 1 | 1997 | 2 | 0.040 |
Why?
| | Protein Structure, Secondary | 1 | 2018 | 325 | 0.040 |
Why?
| | Glucuronosyltransferase | 1 | 1997 | 9 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2019 | 785 | 0.040 |
Why?
| | Camptothecin | 1 | 2017 | 96 | 0.040 |
Why?
| | Prospective Studies | 3 | 2017 | 6220 | 0.030 |
Why?
| | Metal Nanoparticles | 1 | 2018 | 75 | 0.030 |
Why?
| | Solubility | 2 | 2008 | 223 | 0.030 |
Why?
| | Cell Survival | 1 | 2020 | 1021 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 282 | 0.030 |
Why?
| | Exons | 2 | 1997 | 302 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 580 | 0.030 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 180 | 0.030 |
Why?
| | Surface Properties | 1 | 2017 | 387 | 0.030 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2017 | 181 | 0.030 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 156 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2016 | 69 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2019 | 445 | 0.030 |
Why?
| | Medication Adherence | 1 | 2020 | 536 | 0.030 |
Why?
| | Genetic Linkage | 2 | 2007 | 294 | 0.030 |
Why?
| | Autophagy | 1 | 2018 | 235 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 604 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 56 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 10471 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 641 | 0.030 |
Why?
| | Animals, Inbred Strains | 1 | 2015 | 7 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1644 | 0.030 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2015 | 15 | 0.030 |
Why?
| | Histones | 1 | 2019 | 535 | 0.030 |
Why?
| | Genetic Testing | 1 | 1997 | 381 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2019 | 770 | 0.030 |
Why?
| | Codon | 2 | 1992 | 86 | 0.030 |
Why?
| | Heart | 1 | 2018 | 612 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 293 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 768 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 338 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 175 | 0.030 |
Why?
| | Saliva | 2 | 2006 | 188 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 356 | 0.030 |
Why?
| | Gene Frequency | 1 | 2015 | 477 | 0.030 |
Why?
| | Triglycerides | 1 | 2016 | 467 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 398 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1578 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1125 | 0.030 |
Why?
| | Chelation Therapy | 1 | 2013 | 9 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2020 | 1701 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2637 | 0.030 |
Why?
| | Iron Chelating Agents | 1 | 2013 | 16 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2017 | 695 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 1890 | 0.030 |
Why?
| | Mice, Transgenic | 2 | 2010 | 1950 | 0.030 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 561 | 0.030 |
Why?
| | Glucose | 1 | 2017 | 897 | 0.030 |
Why?
| | Child | 3 | 2008 | 18420 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2765 | 0.020 |
Why?
| | Exome | 1 | 2013 | 200 | 0.020 |
Why?
| | Thalassemia | 1 | 1992 | 7 | 0.020 |
Why?
| | Neurons | 1 | 2020 | 1280 | 0.020 |
Why?
| | Placenta | 1 | 2018 | 628 | 0.020 |
Why?
| | Obesity | 1 | 2004 | 2508 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1621 | 0.020 |
Why?
| | Transferrin | 1 | 2011 | 39 | 0.020 |
Why?
| | Blood Cell Count | 1 | 2011 | 50 | 0.020 |
Why?
| | DNA | 3 | 1994 | 1352 | 0.020 |
Why?
| | Liver Function Tests | 1 | 2011 | 103 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 448 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 159 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 10 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 24 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 43 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 139 | 0.020 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 230 | 0.020 |
Why?
| | Antisocial Personality Disorder | 1 | 2011 | 156 | 0.020 |
Why?
| | Contraindications | 1 | 2010 | 85 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1993 | 287 | 0.020 |
Why?
| | Logistic Models | 2 | 2006 | 1841 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5047 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2010 | 75 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 1715 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 283 | 0.020 |
Why?
| | Blood Proteins | 1 | 2011 | 231 | 0.020 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2009 | 5 | 0.020 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2010 | 81 | 0.020 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2009 | 9 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2017 | 9088 | 0.020 |
Why?
| | Corticosterone | 1 | 2010 | 211 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 35 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 2008 | 49 | 0.020 |
Why?
| | New Mexico | 1 | 2008 | 59 | 0.020 |
Why?
| | Social Marketing | 1 | 2008 | 13 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2008 | 239 | 0.020 |
Why?
| | Rural Health | 1 | 2008 | 67 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 923 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2008 | 158 | 0.020 |
Why?
| | Sunlight | 1 | 2008 | 57 | 0.020 |
Why?
| | Pituitary Function Tests | 1 | 2007 | 3 | 0.020 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2007 | 7 | 0.020 |
Why?
| | Fruit | 1 | 2008 | 127 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 524 | 0.020 |
Why?
| | Vegetables | 1 | 2008 | 133 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2009 | 370 | 0.020 |
Why?
| | Adrenal Glands | 1 | 2007 | 66 | 0.020 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 1 | 2006 | 22 | 0.020 |
Why?
| | Acetaldehyde | 1 | 2006 | 15 | 0.020 |
Why?
| | Stochastic Processes | 1 | 2007 | 64 | 0.020 |
Why?
| | Myoglobin | 1 | 2006 | 14 | 0.020 |
Why?
| | Retinal Dehydrogenase | 1 | 2006 | 33 | 0.020 |
Why?
| | Genetic Carrier Screening | 2 | 1997 | 24 | 0.020 |
Why?
| | Pituitary Gland | 1 | 2007 | 148 | 0.020 |
Why?
| | Angiography | 1 | 2007 | 174 | 0.020 |
Why?
| | Osteoclasts | 1 | 2006 | 34 | 0.020 |
Why?
| | Electrophysiology | 1 | 2006 | 201 | 0.020 |
Why?
| | Hip Prosthesis | 1 | 2006 | 33 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2006 | 198 | 0.020 |
Why?
| | Educational Measurement | 1 | 2008 | 243 | 0.020 |
Why?
| | Hormones | 1 | 2006 | 132 | 0.020 |
Why?
| | Bone and Bones | 1 | 2008 | 279 | 0.020 |
Why?
| | Educational Status | 1 | 2008 | 412 | 0.020 |
Why?
| | Phosphorus | 1 | 2006 | 82 | 0.020 |
Why?
| | Reminder Systems | 1 | 2007 | 160 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2006 | 270 | 0.020 |
Why?
| | Physical Endurance | 1 | 2006 | 232 | 0.020 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2006 | 185 | 0.020 |
Why?
| | Neoplasms | 1 | 2018 | 2097 | 0.020 |
Why?
| | Lactic Acid | 1 | 2006 | 275 | 0.010 |
Why?
| | Electromyography | 1 | 2006 | 326 | 0.010 |
Why?
| | Pedigree | 2 | 1997 | 460 | 0.010 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2004 | 49 | 0.010 |
Why?
| | Risk | 1 | 2007 | 812 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2004 | 76 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2004 | 305 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2004 | 195 | 0.010 |
Why?
| | Anthropometry | 1 | 2004 | 183 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 2006 | 669 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 1796 | 0.010 |
Why?
| | Dietary Carbohydrates | 1 | 2004 | 138 | 0.010 |
Why?
| | Interleukin-2 | 1 | 2004 | 413 | 0.010 |
Why?
| | Vitamin D | 1 | 2006 | 341 | 0.010 |
Why?
| | Dietary Fats | 1 | 2004 | 287 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3053 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 4895 | 0.010 |
Why?
| | Odds Ratio | 1 | 2004 | 953 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2004 | 1167 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 641 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 2008 | 756 | 0.010 |
Why?
| | Calcium | 1 | 2006 | 1108 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 2006 | 681 | 0.010 |
Why?
| | Child, Preschool | 2 | 2008 | 9118 | 0.010 |
Why?
| | Viscera | 1 | 1999 | 15 | 0.010 |
Why?
| | Research Design | 1 | 2004 | 928 | 0.010 |
Why?
| | Age Factors | 1 | 2006 | 2894 | 0.010 |
Why?
| | Psychological Tests | 1 | 1999 | 120 | 0.010 |
Why?
| | Cytokines | 1 | 2006 | 1841 | 0.010 |
Why?
| | Pain Measurement | 1 | 2000 | 444 | 0.010 |
Why?
| | Perception | 1 | 2000 | 311 | 0.010 |
Why?
| | Registries | 1 | 2004 | 1768 | 0.010 |
Why?
| | Body Mass Index | 1 | 2004 | 1959 | 0.010 |
Why?
| | Genetics, Population | 1 | 1997 | 188 | 0.010 |
Why?
| | Prenatal Diagnosis | 1 | 1997 | 167 | 0.010 |
Why?
| | Mutation | 2 | 1997 | 3346 | 0.010 |
Why?
| | Homozygote | 1 | 1994 | 187 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2000 | 2540 | 0.010 |
Why?
| | Frameshift Mutation | 1 | 1992 | 27 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 318 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1992 | 993 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 1999 | 4624 | 0.000 |
Why?
| | Infant | 1 | 1997 | 7964 | 0.000 |
Why?
|
|
Saba's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|